The Paediatric Virtual Autopsy Trial

NCT ID: NCT01888380

Last Updated: 2021-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-01

Study Completion Date

2018-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In light of declining autopsy rates around the world, post-mortem MR imaging is a promising alternative to conventional autopsy in the investigation of infant death. A major drawback of this non-invasive autopsy approach is the fact that histopathological and microbiological examination of the tissue is not possible. The objective of this prospective study is to compare the performance of minimally invasive, virtual autopsy, including CT-guided biopsy, with conventional autopsy procedures in a paediatric population.

Foetuses, newborns, infants and children that are referred for autopsy at three different institutions associated with the University of Zurich will be eligible for recruitment. All bodies will be examined with a commercial CT and a 3 Tesla MRI scanner, and investigators will be blinded to the results of conventional autopsy. After cross-sectional imaging, CT-guided tissue sampling will be performed by a multifunctional robotic system (Virtobot) allowing for automated post-mortem biopsies. Virtual autopsy results will be classified with regards to the likely final diagnosis and major pathological findings and compared to the results of conventional autopsy, which remains the diagnostic gold standard.

This interdisciplinary study will determine whether virtual autopsy will narrow the gap in information between non-invasive and traditional autopsy procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stillbirth Newborn Death Sudden Infant Death

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Foetuses

* still birth and termination of pregnancies
* intervention: minimally invasive, virtual autopsy

Group Type EXPERIMENTAL

Minimally invasive, virtual autopsy

Intervention Type PROCEDURE

Post-mortem cross-sectional imaging with CT-guided biopsy

Conventional autopsy

Intervention Type PROCEDURE

Newborns

* who died of natural- and non-natural cause
* intervention: minimally invasive, virtual autopsy

Group Type EXPERIMENTAL

Minimally invasive, virtual autopsy

Intervention Type PROCEDURE

Post-mortem cross-sectional imaging with CT-guided biopsy

Conventional autopsy

Intervention Type PROCEDURE

Children and adolescents

* who died of natural- and non-natural cause
* intervention: minimally invasive, virtual autopsy

Group Type EXPERIMENTAL

Minimally invasive, virtual autopsy

Intervention Type PROCEDURE

Post-mortem cross-sectional imaging with CT-guided biopsy

Conventional autopsy

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Minimally invasive, virtual autopsy

Post-mortem cross-sectional imaging with CT-guided biopsy

Intervention Type PROCEDURE

Conventional autopsy

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Virtopsy Postmortem

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stillborn infants ≥ 16 0/7 weeks of gestational age (GA)
* Live born infants ≥ 16 0/7 weeks GA until adolescents up to 16 years of age, who died of natural- and non-natural cause (trauma, homicide, suicide and intoxication).

Exclusion Criteria

* Deceased infants who are donors of organs
* Lack of parental consent
Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hans Ulrich Bucher, MD, Prof

Role: STUDY_DIRECTOR

University Hospital Zurich, Division of Neonatology

Christoph Rüegger, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Zurich, Division of Neonatology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Zurich, Division of Neonatology

Zurich, Canton of Zurich, Switzerland

Site Status

Division of obstetrics, University Hospital Zurich

Zurich, , Switzerland

Site Status

University Children's Hospital Zurich

Zurich, , Switzerland

Site Status

Zurich Institute for Forensic Medicine

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Ruegger CM, Gascho D, Bode PK, Bruder E, Haslinger C, Ross S, Schmid K, Knopfli C, Hofer LJ, Held L, Martinez RM, Bucher HU; Virtopsy Study Group. Post-mortem magnetic resonance imaging with computed tomography-guided biopsy for foetuses and infants: a prospective, multicentre, cross-sectional study. BMC Pediatr. 2022 Aug 3;22(1):464. doi: 10.1186/s12887-022-03519-4.

Reference Type DERIVED
PMID: 35918685 (View on PubMed)

Ruegger CM, Bartsch C, Martinez RM, Ross S, Bolliger SA, Koller B, Held L, Bruder E, Bode PK, Caduff R, Frey B, Schaffer L, Bucher HU. Minimally invasive, imaging guided virtual autopsy compared to conventional autopsy in foetal, newborn and infant cases: study protocol for the paediatric virtual autopsy trial. BMC Pediatr. 2014 Jan 20;14:15. doi: 10.1186/1471-2431-14-15.

Reference Type DERIVED
PMID: 24438163 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Paediatric virtopsy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.